Yuma Waki

9PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Sep 06, 2026
Outcomes of Curative-Intent Endoscopic Resection Combined With Adjuvant Immune Checkpoint Inhibition for Resectable Sinonasal Mucosal Melanoma.

|Apr 08, 2026
Clinical Features of Nasal and Paranasal Mucosal Melanomas in the Era of Immune Checkpoint Inhibitors: Insights From a Single-Institution Analysis.

Yuma Waki, Teru Ebihara, Kazuhiro Omura

|Apr 27, 2022
Successful treatment with dacarbazine against a parathyroid hormone-related protein-producing melanoma causing hypercalcemia after immune checkpoint inhibitor failure.

Yuma Waki, Yoshimasa Nobeyama, Fuminori Katsumata

Pageof 2

Frequent Collaborators

7 joint publications

Yoshimasa Nobeyama

2 joint publications

Fuminori Katsumata

1 joint publications

Akihiko Asahina

1 joint publications

Hidemi Nakagawa

1 joint publications

Teru Ebihara

1 joint publications

Soichiro Fukuzato

1 joint publications

Kazuhiro Omura

Frequent Collaborators

7 joint publications

Yoshimasa Nobeyama

2 joint publications

Fuminori Katsumata

1 joint publications

Akihiko Asahina

1 joint publications

Hidemi Nakagawa

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us